An ABPI survey has shown the depth of public misunderstanding over the cost and value of medicines in the UK. Thirty-five per cent thought 20 per cent or more of the NHS budget was spent on medicines, while 59 per cent thought it cost pharma companies less than £10m to develop a medicine. In reality, the NHS spent 9.7 per cent of its budget on medicines, while the cost of developing a new medicine is on average £1bn.
Axon Communications has hired Sophie Ivison as programme executive. She was formerly team co-ordinator at Weber Shandwick.
Roche's Pascal Soriot has joined AstraZeneca as its new chief executive. He has been COO of Roche's $34bn pharma division since 2010.
Hickson Communications will extend its project work with diabetes alliance Euradia to include longer-term strategy.